IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge

We have learned a great deal in the process of developing and executing our internal procedures for this clinical trial. Our description of the IGV-001 protocol workflow may serve as a "blueprint" for future implementation of this type of cellular immunotherapy at other centers. We further discuss some of the lessons we have learned during the trial.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-03-18
DOI
https://doi.org/10.3389/fonc.2025.1556450
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge

Athar N. Malik, Curt Doberstein, John E. Donahue, Jennifer Dailey et al.
Frontiers in Oncology
CAR-T cell therapy research
article

IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge

Athar N. Malik, Curt Doberstein, John E. Donahue, Jennifer Dailey, Attila A. Seyhan, Sasmit Sarangi, Konstantina A. Svokos, Hael Abdulrazeq, Neil P. Rodrigues, Heinrich Elinzano, Rahul A. Sastry, Esther Yee Tak Yu, Belinda Shao, Joshua Feler, Tori Riccelli, Ziya L. Gokaslan, Elaina Wang, Carlin Chuck, Elias Shaaya, Deus Cielo, Sharonda E. Keith, Howard Safran, Michael Punsoni, Wafik S. El‐Deiry, Rohaid Ali, Fei Sun, Christine Yu, Prakash Sampath, Clark C. Chen, Jerrold L. Boxerman, Eric T. Wong, Robert P. Edwards, Santos E. Santos Fontánez, Natalie Amaral Nieves, Cody Dobertsein, Francesca Rothell
article en

Abstract

We have learned a great deal in the process of developing and executing our internal procedures for this clinical trial. Our description of the IGV-001 protocol workflow may serve as a "blueprint" for future implementation of this type of cellular immunotherapy at other centers. We further discuss some of the lessons we have learned during the trial.

Frontiers in OncologyVol. 15
Brown University (US), Rhode Island Hospital (US)
Openalex Percentile: Top 93%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.